Pacific Edge awarded Japanese patent for colorectal cancer, shares rise

Pacific Edge awarded Japanese patent for colorectal cancer, shares rise
By Suze Metherell Sept. 25 (BusinessDesk) - Pacific Edge, the medical biotech company, has been awarded a Japanese patent for its colorectal cancer screening technology, as the company looks to expand its range of diagnostic tests internationally. The shares rose on open.  The Dunedin-based biotech is looking to commercialise its Cxcolorectal test in Japan, where colorectal is the nation's most prevalent cancer, it said in a statement. The test, which is in the late stages of development, will detect aggressive cancer in patients who have...